Home
Sutro Biopharma

Sutro Biopharma Market Share Analysis for May 2026

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing.

Health > Biotechnology and Pharmaceuticals

Domainsutrobio.com

Year Founded2003

Employees201 - 500

Annual Revenue$100M - $200M

Sutro Biopharma

Sutro Biopharma (including company regionals)

sutrobio.com

See more website traffic and engagement information

Sutro Biopharma Revenue up to May 2026 is 100M - 200M

revenue generated by Sutro Biopharma top domains

Sutro Biopharma top domains revenue over 3 years

Revenue for Sutro Biopharma top domains

sutrobio.com100M - 200M

See more with Sales Intelligence

Total visits to Sutro Biopharma's top domains

Understand Sutro Biopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sutrobio.com13.6K

See more with Sales Intelligence

Avg. visit duration in Sutro Biopharma's top domains

Analyze Sutro Biopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sutrobio.com00:00:20

See more with Sales Intelligence

Avg. pageviews on Sutro Biopharma's top domains

See how Sutro Biopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sutrobio.com1.76

See more with Sales Intelligence

Sutro Biopharma top competitors by domain

Top similar sites in May 2026, ranked by their affinity

vaxcyte.comCompany NameVaxcyteEmployees201 - 500HQUnited States, California, San CarlosAnnual revenue$25M - $50MTotal visits10.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sutro Biopharma

These are the website technologies, by industry, used by Sutro Biopharma top domains

Widget (4)

Twemoji

Audio Video Media (3)

YouTube

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

More Technologies

12

See all

News & Signals from Sutro Biopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSutro Biopharma, Inc is planning to receive financing of $110M.Sutro Biopharma announces pricing of $110.0 million underwritten offering.

NewsSutro Biopharma, Inc attended event Research & Development Day on Nov 12th '25.SOUTH SAN FRANCISCO, Calif., November 5, 2025 - Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it will host a virtual Research & Development Day, highlighting the details of its platform innovation and next-generation ADC pipeline.

NewsSutro Biopharma, Inc attended event 16th Annual World ADC Conference on Jan 1st '25.Sutro Biopharma announces participation at the 16th Annual World ADC Conference.